Major histocompatibility complex (MHC) class II molecules are highly p
olymorphic and bind peptides for presentation to CD4(+) T cells. Funct
ional and adhesion assays have shown that CD4 interacts with MHC class
II molecules, leading to enhanced responses of CD4(+) T cells after t
he activation of the CD4-associated tyrosine kinase p56(lck). We have
addressed the possible contribution of allelic polymorphism in the int
eraction between CD4 and MHC class II molecules. Using mouse DAP-3-tra
nsfected cells expressing different isotypes and allelic forms of the
HLA-DR molecule, we have shown in a functional assay that a hierarchy
exists in the ability of class II molecules to interact with CD4. Also
, the study of DR4 subtypes minimized the potential contribution of po
lymorphic residues of the peptide-binding groove in the interaction wi
th CD4. Chimeras between the DR4 or DR1 molecules, which interact effi
ciently with CD4, and DRw53, which interacts poorly, allowed the mappi
ng of polymorphic residues between positions beta 180 and 189 that can
exert a dramatic influence on the interaction with CD4.